Robbins Umeda LLP, a shareholder rights litigation firm, is interested in helping shareholders of National Semiconductor Corporation (NYSE:NSM). The Firm has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of National Semiconductor in connection with their efforts to be acquired by Texas Instruments Incorporated (NYSE:TI).
If you own stock in National Semiconductor and would like more information about your shareholder rights, please contact Gregory E. Del Gaizo at 800-350-6003 or via the shareholder information form on our website.
On April 4, 2011, National Semiconductor announced it has entered into a definitive merger agreement under which National Semiconductor will be acquired by Texas Instruments in an all-cash transaction. Under the current agreement, National Semiconductor shareholders will receive $25 in cash for each share of National Semiconductor common stock they hold. The transaction is expected to close in six to nine months.
The investigation is focused on whether National Semiconductor's board is undertaking a fair process to obtain maximum value for its shareholders. Of particular interest, under the terms of the agreement, National Semiconductor may not solicit acquisition proposals from third parties. In addition, the agreement includes a $200 million termination fee.
Robbins Umeda LLP represents individual and institutional shareholders in derivative, direct, and class action lawsuits. The Firm's skilled litigation teams include former federal prosecutors, former defense counsel from top multinational corporate law firms, and career shareholder rights attorneys. Robbins Umeda LLP has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsumeda.com.
Press release link: http://www.robbinsumeda.com/shareholders-rights-blog/national-semiconductor-corp/
Attorney Advertising. Past results do not guarantee a similar outcome.
Contacts:
Gregory E. Del Gaizo, 800-350-6003
